Pharmaceutical market access in emerging markets: concepts, components, and future
This article intends to consolidate the concepts of pharmaceutical market access and highlight its growing importance in emerging markets.Market access has gained considerable attention worldwide as countries try to contain their escalating healthcare expenditures amidst the global economic slowdown...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2014-12-01
|
| Series: | Journal of Market Access & Health Policy |
| Subjects: | |
| Online Access: | http://www.jmahp.net/index.php/jmahp/article/download/25302/37161 |
| _version_ | 1797229459822084096 |
|---|---|
| author | Anuj Kumar Karthaveerya Juluru Phani Kishore Thimmaraju Jayachandra Reddy Anand Patil |
| author_facet | Anuj Kumar Karthaveerya Juluru Phani Kishore Thimmaraju Jayachandra Reddy Anand Patil |
| author_sort | Anuj Kumar |
| collection | DOAJ |
| description | This article intends to consolidate the concepts of pharmaceutical market access and highlight its growing importance in emerging markets.Market access has gained considerable attention worldwide as countries try to contain their escalating healthcare expenditures amidst the global economic slowdown. This has resulted in governments adopting stricter measures for new product approval. Thus, pharmaceutical companies are finding it increasingly difficult to successfully address the specific challenges posed by various government and regulatory agencies and stakeholders.There is an increasing need to establish market access functions, especially in emerging markets, where the complex, dynamic healthcare landscape confounds product approval and uptake. Moreover, emerging markets are the engines of growth today, and, thus, performing in these markets is critical for the majority of pharmaceutical companies.To address the challenges posed by regulatory agencies and diverse stakeholders, a customized market access strategy is the need of the hour. A market access framework with specific tools and tactics will help companies to plan, implement, and monitor stakeholder engagement activities. |
| first_indexed | 2024-04-24T15:12:56Z |
| format | Article |
| id | doaj.art-89749d7d529245a98259dfde0fd34aad |
| institution | Directory Open Access Journal |
| issn | 2001-6689 |
| language | English |
| last_indexed | 2024-04-24T15:12:56Z |
| publishDate | 2014-12-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Journal of Market Access & Health Policy |
| spelling | doaj.art-89749d7d529245a98259dfde0fd34aad2024-04-02T09:54:06ZengMDPI AGJournal of Market Access & Health Policy2001-66892014-12-01201410.3402/jmahp.v2.2530225302Pharmaceutical market access in emerging markets: concepts, components, and futureAnuj Kumar0Karthaveerya Juluru1Phani Kishore Thimmaraju2Jayachandra Reddy3Anand Patil4phamax Analytical Resource Pvt. Ltd., Bangalore, Indiaphamax Analytical Resource Pvt. Ltd., Bangalore, Indiaphamax Analytical Resource Pvt. Ltd., Bangalore, Indiaphamax Analytical Resource Pvt. Ltd., Bangalore, Indiaphamax Analytical Resource Pvt. Ltd., Bangalore, IndiaThis article intends to consolidate the concepts of pharmaceutical market access and highlight its growing importance in emerging markets.Market access has gained considerable attention worldwide as countries try to contain their escalating healthcare expenditures amidst the global economic slowdown. This has resulted in governments adopting stricter measures for new product approval. Thus, pharmaceutical companies are finding it increasingly difficult to successfully address the specific challenges posed by various government and regulatory agencies and stakeholders.There is an increasing need to establish market access functions, especially in emerging markets, where the complex, dynamic healthcare landscape confounds product approval and uptake. Moreover, emerging markets are the engines of growth today, and, thus, performing in these markets is critical for the majority of pharmaceutical companies.To address the challenges posed by regulatory agencies and diverse stakeholders, a customized market access strategy is the need of the hour. A market access framework with specific tools and tactics will help companies to plan, implement, and monitor stakeholder engagement activities.http://www.jmahp.net/index.php/jmahp/article/download/25302/37161pharmaceutical market accessemerging marketsdeveloped marketsstakeholdersmarket access frameworkescalating healthcare costpricing and reimbursement |
| spellingShingle | Anuj Kumar Karthaveerya Juluru Phani Kishore Thimmaraju Jayachandra Reddy Anand Patil Pharmaceutical market access in emerging markets: concepts, components, and future Journal of Market Access & Health Policy pharmaceutical market access emerging markets developed markets stakeholders market access framework escalating healthcare cost pricing and reimbursement |
| title | Pharmaceutical market access in emerging markets: concepts, components, and future |
| title_full | Pharmaceutical market access in emerging markets: concepts, components, and future |
| title_fullStr | Pharmaceutical market access in emerging markets: concepts, components, and future |
| title_full_unstemmed | Pharmaceutical market access in emerging markets: concepts, components, and future |
| title_short | Pharmaceutical market access in emerging markets: concepts, components, and future |
| title_sort | pharmaceutical market access in emerging markets concepts components and future |
| topic | pharmaceutical market access emerging markets developed markets stakeholders market access framework escalating healthcare cost pricing and reimbursement |
| url | http://www.jmahp.net/index.php/jmahp/article/download/25302/37161 |
| work_keys_str_mv | AT anujkumar pharmaceuticalmarketaccessinemergingmarketsconceptscomponentsandfuture AT karthaveeryajuluru pharmaceuticalmarketaccessinemergingmarketsconceptscomponentsandfuture AT phanikishorethimmaraju pharmaceuticalmarketaccessinemergingmarketsconceptscomponentsandfuture AT jayachandrareddy pharmaceuticalmarketaccessinemergingmarketsconceptscomponentsandfuture AT anandpatil pharmaceuticalmarketaccessinemergingmarketsconceptscomponentsandfuture |